Public health department response to mercury poisoning: the importance of biomarkers and risks and benefits analysis for chelation therapy.

J Med Toxicol

Division of Medical Toxicology, Department of Emergency Medicine, Hartford Hospital/University of Connecticut School of Medicine, American College of Medical Toxicology, 10645 N. Tatum Blvd. Suite 200-111, Phoenix, AZ, 85028, USA,

Published: December 2013

AI Article Synopsis

  • Chelation therapy is commonly used for treating mercury poisoning, prompting public health discussions about its effectiveness and safety.
  • The paper addresses concerns regarding mercury-containing cosmetics in Minnesota and presents two unpublished cases linked to potential mercury toxicity treated with chelation.
  • Physicians are urged to carefully assess mercury exposure sources and weigh the risks and benefits of chelation therapy, as potential adverse effects remain a significant public health issue.

Article Abstract

Chelation therapy is often used to treat mercury poisoning. Public health personnel are often asked about mercury toxicity and its treatment. This paper provides a public health department response to use of a mercury-containing cosmetic in Minnesota, a perspective on two unpublished cases of chelation treatment for postulated mercury toxicity, and comments on the use of a nonsystemic treatment for removal of mercury following the Iraqi seed coat poisoning incident. Physicians should evaluate sources of exposure, biomarkers, and risks and benefits before recommending chelation therapy for their patients. Potential risks to chelation therapy and its little understood subtle or latent effects are areas of public health concern.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846980PMC
http://dx.doi.org/10.1007/s13181-013-0340-9DOI Listing

Publication Analysis

Top Keywords

public health
16
chelation therapy
16
health department
8
department response
8
mercury poisoning
8
biomarkers risks
8
risks benefits
8
mercury toxicity
8
mercury
5
chelation
5

Similar Publications

Background: Billions of dollars have been spent implementing regulations to reduce traffic-related air pollution (TRAP) from exhaust pipe emissions. However, few health studies have evaluated the change in TRAP emissions and associations with infant health outcomes. We hypothesize that the magnitude of association between vehicle exposure measures and adverse birth outcomes has decreased over time, parallelling regulatory improvements in exhaust pipe emissions.

View Article and Find Full Text PDF

(Group A Streptococcus, GAS) is a human pathogen that causes local and systemic infections of the skin and mucous membranes. However, GAS is also found asymptomatically in the nasopharynx of infants. GAS infections, including pharyngitis and invasive pneumosepsis, pose significant public health concerns.

View Article and Find Full Text PDF

Objective: Elevated blood pressure (BP), even at prehypertensive levels, increases cardiovascular disease risk among people with HIV (PWH); yet international guidelines in low-income countries recommend treatment initiation at BP at least 140/90 mmHg. We determined the efficacy, feasibility, and acceptability of treating prehypertension in PWH in Haiti.

Design: An unblinded randomized clinical trial (enrolled April 2021-March 2022) with 12-month follow-up.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!